|
1. Falahi S, Kenarkoohi A. Host factors and vaccine efficacy: implications for COVID‐19 vaccines. J Med Virol. 2022;94:1330-5. doi: 10.1002/jmv.27485. 2. Rayatdoost E, Rahmanian M, Sanie MS, Rahmanian J, Matin S, Kalani N, et al. Sufficient sleep, time of vaccination, and vaccine efficacy: a systematic review of the current evidence and a proposal for COVID-19 vaccination. Yale J Biol Med. 2022;95:221. 3. Falahi S, Abdoli A, Kenarkoohi A. Claims and reasons about mild COVID-19 in children. New Microb New Infec. 2021;41:100864. doi: 10.1016/j.nmni.2021.100864. 4. Falahi S, Abdoli A, Kenarkoohi A. Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives. New Microb New Infec. 2023;53:101135. doi: 10.1016/j.nmni.2023.101135. 5. Falahi S, Kenarkoohi A. Sex and gender differences in the outcome of patients with COVID‐19. J Med Virol. 2020;93:151. doi: 10.1002/jmv.26243. 6. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144:799-805. doi: 10.5858/arpa.2020-0901-SA. 7. Abdoli A, Falahi S, Kenarkoohi A, Shams M, Mir H, Jahromi MAM. The COVID-19 pandemic, psychological stress during pregnancy, and risk of neurodevelopmental disorders in offspring: a neglected consequence. J Psychosom Obstet Gynecol. 2020;41:247-8. doi: 10.1080/0167482X.2020.1761321. 8. Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol. 2012;207:S3-S8. doi: 10.1016/j.ajog.2012.06.068. 9. Ai-ris YC, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J, et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA. 2021;325:2370-80. doi: 10.1001/jama.2021.7563. 10. Al-Momani H, Aldajah K, Alda'ajah E, ALjafar Y, Abushawer Z. Effectiveness of Pfizer/BioNTech and Sinopharm COVID-19 vaccines in reducing hospital admissions in prince Hamza hospital, Jordan. Front Public Health. 2022;10:1008521. doi: 10.3389/fpubh.2022.1008521. 11. Etemadifar M, Abhari AP, Nouri H, Sigari AA, Piran Daliyeh SM, Maracy MR, et al. Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. Hum Vaccin Immunother. 2022;18:2041945. doi: 10.1080/21645515.2022.2041945. 12. Jeewandara C, Jayampathi KCS, Ranasinghe T, Aberathna IS, Gunasekara B, Danasekara S, et al. Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka. PLOS Glob Public Health. 2022;2:e0000607. doi: 10.1371/journal.pgph.0000607. 13. Bianchi DW, Kaeser L, Cernich AN. Involving pregnant individuals in clinical research on COVID-19 vaccines. JAMA. 2021;325:1041-2. doi: 10.1001/jama.2021.1865. 14. Abdolahi T, Maamouri G, Behmadi M, Mirzaeian S, Boskabadi H, Faramarzi R. Investigating the impact of Sinopharm COVID‐19 vaccination on antibody response in pregnant women and their newborns. J Med Virol. 2023;95:e29231. doi: 10.1002/jmv.29231. 15. Hantoushzadeh S, Eshraghi N, Younesi S, Salehi M, Rezaei N, Hasheminejad MM, et al. Cord blood antibodies following BBIBP‐CorV (Sinopharm) vaccination during pregnancy. Immun inflamm dis. 2023;11:e874. doi: 10.1002/iid3.874. 16. Alirezaei A, Fazeli SA, Shafiei M, Miladipour A. Efficacy of Sinopharm® COVID-19 Vaccine in Hemodialysis Patients: A Preliminary Report. Iran J Kidney Dis. 2022;16. doi: magiran.com/p2470770. 17. Karimi M, Zarei T, Haghpanah S, Azarkeivan A, Naderi M, Matin S, et al. Efficacy and safety of sinopharm vaccine for SARS-CoV-2 and breakthrough infections in iranian patients with hemoglobinopathies: a preliminary report. Mediterr J Hematol Infect Dis. 2022;14:e2022026. doi: 10.4084/MJHID.2022.026. 18. Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021;27:1693-5. doi: 10.1038/s41591-021-01490-8. 19. Bookstein Peretz S, Regev N, Novick L, Nachshol M, Goffer E, Ben‐David A, et al. Short‐term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID‐19 vaccine. Ultrasound Obstet Gynecol. 2021;58:450-6. doi: 10.1002/uog.23729. 20. Chansaenroj J, Yorsaeng R, Posuwan N, Puenpa J, Wanlapakorn N, Sudhinaraset N, et al. Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients. Sci Rep. 2021;11:23216. doi: 10.1038/s41598-021-02659-4.
|
